A general chemical principle for creating closure-stabilizing integrin inhibitors

Lin, Fu-Yang; Li, Jing; Xie, Yonghua; Zhu, Jianghai; Nguyen, Thi Thu Huong; Zhang, Yonghui; Zhu, Jieqing; Springer, Timothy A.

doi:10.1016/j.cell.2022.08.008

A general chemical principle for creating closure-stabilizing integrin inhibitors

Journal Article · 01 September 2022 · Cell

DOI:https://doi.org/10.1016/j.cell.2022.08.008· OSTI ID:1901102

Lin, Fu-Yang; Li, Jing; Xie, Yonghua; Zhu, Jianghai; Nguyen, Thi Thu Huong; Zhang, Yonghui; Zhu, Jieqing; Springer, Timothy A.

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; NIH

OSTI ID:: 1901102

Journal Information:: Cell, Journal Name: Cell Journal Issue: (19) Vol. 185

Country of Publication:: United States

Language:: ENGLISH

References (83)

Therapeutic antagonists and conformational regulation of integrin function Shimaoka, Motomu; Springer, Timothy A. Nature Reviews Drug Discovery, Vol. 2, Issue 9 https://doi.org/10.1038/nrd1174	journal	September 2003
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics Xiao, Tsan; Takagi, Junichi; Coller, Barry S. Nature, Vol. 432, Issue 7013 https://doi.org/10.1038/nature02976	journal	September 2004
A Specific Interface between Integrin Transmembrane Helices and Affinity for Ligand Luo, Bing-Hao; Springer, Timothy A.; Takagi, Junichi PLoS Biology, Vol. 2, Issue 6 https://doi.org/10.1371/journal.pbio.0020153	journal	June 2004
Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3 Newman, Pj; Allen, Rw; Kahn, Ra Blood, Vol. 65, Issue 1 https://doi.org/10.1182/blood.V65.1.227.227	journal	January 1985
Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β Campbell, Melody G.; Cormier, Anthony; Ito, Saburo Cell, Vol. 180, Issue 3 https://doi.org/10.1016/j.cell.2019.12.030	journal	February 2020
Platelet GPIIb-IIIa blockers Topol, Eric J.; Byzova, Tatiana V.; Plow, Edward F. The Lancet, Vol. 353, Issue 9148 https://doi.org/10.1016/S0140-6736(98)11086-3	journal	January 1999
An internal ligand-bound, metastable state of a leukocyte integrin, α _X β ₂ Sen, Mehmet; Yuki, Koichi; Springer, Timothy A. The Journal of Cell Biology, Vol. 203, Issue 4 https://doi.org/10.1083/jcb.201308083	journal	November 2013
The Enantiospecific Synthesis of an Isoxazoline. A RGD Mimic Platelet GPIIb/IIIa Antagonist Zhang, Lin-hua; Chung, J. C.; Costello, T. D. The Journal of Organic Chemistry, Vol. 62, Issue 8 https://doi.org/10.1021/jo9612537	journal	April 1997
Structural specializations of α ₄ β ₇ , an integrin that mediates rolling adhesion Yu, Yamei; Zhu, Jianghai; Mi, Li-Zhi The Journal of Cell Biology, Vol. 196, Issue 1 https://doi.org/10.1083/jcb.201110023	journal	January 2012
Structural insights into integrin α ₅ β ₁ opening by fibronectin ligand Schumacher, Stephanie; Dedden, Dirk; Nunez, Roberto Vazquez Science Advances, Vol. 7, Issue 19 https://doi.org/10.1126/sciadv.abe9716	journal	May 2021
Delayed profound thrombocytopenia associated with eptifibatide Onitilo, Adedayo A. American Journal of Hematology, Vol. 81, Issue 12 https://doi.org/10.1002/ajh.20609	journal	December 2006
Delayed tirofiban-induced thrombocytopenia: two case reports Bosco, A.; Kidson-Gerber, G.; Dunkley, S. Journal of Thrombosis and Haemostasis, Vol. 3, Issue 5 https://doi.org/10.1111/j.1538-7836.2005.01296.x	journal	May 2005
UR-3216: A Manageable Oral GPIIb/IIIa Antagonist Baba, Kosuke; Aga, Yasuhiro; Nakanishi, Takayuki Cardiovascular Drug Reviews, Vol. 19, Issue 1 https://doi.org/10.1111/j.1527-3466.2001.tb00181.x	journal	June 2006
Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations Li, Jihong; Fukase, Yoshiyuki; Shang, Yi ACS Pharmacology & Translational Science, Vol. 2, Issue 6 https://doi.org/10.1021/acsptsci.9b00041	journal	August 2019
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
"Panning" for lymphocytes: a method for cell selection. Wysocki, L. J.; Sato, V. L. Proceedings of the National Academy of Sciences, Vol. 75, Issue 6 https://doi.org/10.1073/pnas.75.6.2844	journal	June 1978
Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes Cox, Dermot; Smith, Richard; Quinn, Martin Journal of the American College of Cardiology, Vol. 36, Issue 5 https://doi.org/10.1016/S0735-1097(00)00919-0	journal	November 2000
Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists Tilley, Jefferson W.; Sidduri, Achyutharao; Lou, Jianping Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 4 https://doi.org/10.1016/j.bmcl.2012.12.019	journal	February 2013
Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the β1 subunit Mould, A. Paul; Garratt, Alistair N.; Askari, Janet A. FEBS Letters, Vol. 363, Issue 1-2 https://doi.org/10.1016/0014-5793(95)00301-O	journal	April 1995
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor Nagae, Masamichi; Re, Suyong; Mihara, Emiko The Journal of Cell Biology, Vol. 197, Issue 1 https://doi.org/10.1083/jcb.201111077	journal	March 2012
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction Trip, Mieke D.; Cats, Volkert Manger; van Capelle, Frans J. L. New England Journal of Medicine, Vol. 322, Issue 22 https://doi.org/10.1056/NEJM199005313222201	journal	May 1990
Anti-integrin monoclonal antibodies Byron, A.; Humphries, J. D.; Askari, J. A. Journal of Cell Science, Vol. 122, Issue 22 https://doi.org/10.1242/jcs.056770	journal	November 2009
Platelet Activation in Unstable Coronary Disease Fitzgerald, Desmond J.; Roy, Louis; Catella, Francesca New England Journal of Medicine, Vol. 315, Issue 16 https://doi.org/10.1056/NEJM198610163151602	journal	October 1986
Pentamidine Is a Specific, Non-Peptide, GPIIb/llla Antagonist Cox, Dermot; Aoki, Toshiaki; Seki, Jiro Thrombosis and Haemostasis, Vol. 75, Issue 03 https://doi.org/10.1055/s-0038-1650305	journal	January 1996
Structural mechanism of laminin recognition by integrin Arimori, Takao; Miyazaki, Naoyuki; Mihara, Emiko Nature Communications, Vol. 12, Issue 1 https://doi.org/10.1038/s41467-021-24184-8	journal	June 2021
Physiological Models Are Good Tools to Predict Rat Bioavailability of EF5154 Prodrugs from In Vitro Intestinal Parameters Nomoto, Masahiro; Tatebayashi, Tomoko; Morita, Jun Journal of Pharmaceutical Sciences, Vol. 98, Issue 4 https://doi.org/10.1002/jps.21510	journal	April 2009
Structural determinants of integrin β-subunit specificity for latent TGF-β Dong, Xianchi; Hudson, Nathan E.; Lu, Chafen Nature Structural & Molecular Biology, Vol. 21, Issue 12 https://doi.org/10.1038/nsmb.2905	journal	November 2014
Identification and characterization of antibodies that bind GPIIb/IIIa: Antagonist complexes Breth, Leah; Kochie, Jennifer; Combs, Amanda Journal of Immunological Methods, Vol. 301, Issue 1-2 https://doi.org/10.1016/j.jim.2005.02.008	journal	June 2005
Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling Takagi, Junichi; Petre, Benjamin M.; Walz, Thomas Cell, Vol. 110, Issue 5 https://doi.org/10.1016/S0092-8674(02)00935-2	journal	September 2002
Regulation of integrin α5β1 conformational states and intrinsic affinities by metal ions and the ADMIDAS Anderson, Jordan M.; Li, Jing; Springer, Timothy A. Molecular Biology of the Cell, Vol. 33, Issue 6 https://doi.org/10.1091/mbc.E21-11-0536	journal	May 2022
Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists Chew, Derek P.; Bhatt, Deepak L.; Sapp, Shelly Circulation, Vol. 103, Issue 2 https://doi.org/10.1161/01.CIR.103.2.201	journal	January 2001
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 in Complex with an Arg-Gly-Asp Ligand Xiong, J. -P. Science, Vol. 296, Issue 5565 https://doi.org/10.1126/science.1069040	journal	March 2002
Clot Retraction: Cellular Mechanisms and Inhibitors, Measuring Methods, and Clinical Implications Jansen, Ellen E.; Hartmann, Matthias Biomedicines, Vol. 9, Issue 8 https://doi.org/10.3390/biomedicines9081064	journal	August 2021
An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice Mitjans, F.; Sander, D.; Adan, J. Journal of Cell Science, Vol. 108, Issue 8 https://doi.org/10.1242/jcs.108.8.2825	journal	August 1995
New antithrombotic RGD-mimetics with high bioavailability Gante, Joachim; Juraszyk, Horst; Raddatz, Peter Bioorganic & Medicinal Chemistry Letters, Vol. 6, Issue 20 https://doi.org/10.1016/0960-894X(96)00445-3	journal	October 1996
Integrin-based therapeutics: biological basis, clinical use and new drugs Ley, Klaus; Rivera-Nieves, Jesus; Sandborn, William J. Nature Reviews Drug Discovery, Vol. 15, Issue 3 https://doi.org/10.1038/nrd.2015.10	journal	January 2016
Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. Frelinger, A. L.; Cohen, I.; Plow, E. F. Journal of Biological Chemistry, Vol. 265, Issue 11 https://doi.org/10.1016/S0021-9258(19)39332-9	journal	April 1990
Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist Chiba, Jun; Machinaga, Nobuo; Takashi, Tohru Bioorganic & Medicinal Chemistry Letters, Vol. 15, Issue 1 https://doi.org/10.1016/j.bmcl.2004.10.041	journal	January 2005
Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa. Kekomaki, R.; Dawson, B.; McFarland, J. Journal of Clinical Investigation, Vol. 88, Issue 3 https://doi.org/10.1172/JCI115386	journal	September 1991
GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster Matsuno, Hiroyuki; Kozawa, Osamu; Niwa, Masayuki British Journal of Pharmacology, Vol. 122, Issue 6 https://doi.org/10.1038/sj.bjp.0701500	journal	November 1997
Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture. Miyake, K.; Hasunuma, Y.; Yagita, H. Journal of Cell Biology, Vol. 119, Issue 3 https://doi.org/10.1083/jcb.119.3.653	journal	November 1992
Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand Luo, B. -H.; Springer, T. A.; Takagi, J. Proceedings of the National Academy of Sciences, Vol. 100, Issue 5 https://doi.org/10.1073/pnas.0438060100	journal	February 2003
New peptidomimetics in the chemistry of fibrinogen receptor antagonists Gante, J.; Juraszyk, H.; Raddatz, P. Letters in Peptide Science, Vol. 2, Issue 3-4 https://doi.org/10.1007/BF00119139	journal	January 1995
A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1. Lenter, M.; Uhlig, H.; Hamann, A. Proceedings of the National Academy of Sciences, Vol. 90, Issue 19 https://doi.org/10.1073/pnas.90.19.9051	journal	October 1993
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial Miller, David H.; Weber, Thomas; Grove, Richard The Lancet Neurology, Vol. 11, Issue 2 https://doi.org/10.1016/S1474-4422(11)70299-X	journal	February 2012
Integrin extension enables ultrasensitive regulation by cytoskeletal force Li, Jing; Springer, Timothy A. Proceedings of the National Academy of Sciences, Vol. 114, Issue 18 https://doi.org/10.1073/pnas.1704171114	journal	April 2017
Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. Akiyama, S. K.; Yamada, S. S.; Chen, W. T. Journal of Cell Biology, Vol. 109, Issue 2 https://doi.org/10.1083/jcb.109.2.863	journal	August 1989
Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin Bougie, Daniel W.; Rasmussen, Mark; Zhu, Jieqing Blood, Vol. 119, Issue 26 https://doi.org/10.1182/blood-2012-01-406322	journal	June 2012
Metal ion and ligand binding of integrin α ₅ β ₁ Xia, Wei; Springer, Timothy A. Proceedings of the National Academy of Sciences, Vol. 111, Issue 50 https://doi.org/10.1073/pnas.1420645111	journal	December 2014
Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease Topol, Eric J.; Easton, Donald; Harrington, Robert A. Circulation, Vol. 108, Issue 4 https://doi.org/10.1161/01.CIR.0000084501.48570.F6	journal	July 2003
Structure-Guided Design of a High-Affinity Platelet Integrin IIb 3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS Zhu, J.; Choi, W. -S.; McCoy, J. G. Science Translational Medicine, Vol. 4, Issue 125 https://doi.org/10.1126/scitranslmed.3003576	journal	March 2012
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening Zhu, Jieqing; Zhu, Jianghai; Negri, Ana Blood, Vol. 116, Issue 23 https://doi.org/10.1182/blood-2010-04-281154	journal	December 2010
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors Reynolds, Andrew R.; Hart, Ian R.; Watson, Alan R. Nature Medicine, Vol. 15, Issue 4 https://doi.org/10.1038/nm.1941	journal	March 2009
CuI-Catalyzed Coupling Reaction of β-Amino Acids or Esters with Aryl Halides at Temperature Lower Than That Employed in the Normal Ullmann Reaction. Facile Synthesis of SB-214857 Ma, Dawei; Xia, Chengfeng Organic Letters, Vol. 3, Issue 16 https://doi.org/10.1021/ol016258r	journal	July 2001
Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis Adair, Brian D.; Alonso, José L.; van Agthoven, Johannes Nature Communications, Vol. 11, Issue 1 https://doi.org/10.1038/s41467-019-13928-2	journal	January 2020
Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist Muro, Fumihito; Iimura, Shin; Sugimoto, Yuuichi Journal of Medicinal Chemistry, Vol. 52, Issue 24 https://doi.org/10.1021/jm901154c	journal	November 2009
Profound and Sustained Inhibition of Platelet Aggregation by Fradafiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, and Its Orally Active Prodrug, Lefradafiban, in Men Müller, Thomas H.; Weisenberger, Hans; Brickl, Rolf Circulation, Vol. 96, Issue 4 https://doi.org/10.1161/01.CIR.96.4.1130	journal	August 1997
Platelet Glycoprotein IIb-IIIa Antagonists as Prototypical Integrin Blockers: Novel Parenteral and Potential Oral Antithrombotic Agents Scarborough, Robert M.; Gretler, Daniel D. Journal of Medicinal Chemistry, Vol. 43, Issue 19 https://doi.org/10.1021/jm000022w	journal	August 2000
Effect of GR144053, a Fibrinogen-Receptor Antagonist, on Thrombus Formation and Vascular Patency After Thrombolysis by tPA in the Injured Carotid Artery of the Hamster Matsuno, Hiroyuki; Kozawa, Osamu; Niwa, Masayuki Journal of Cardiovascular Pharmacology, Vol. 32, Issue 2 https://doi.org/10.1097/00005344-199808000-00004	journal	August 1998
General structural features that regulate integrin affinity revealed by atypical αVβ8 Wang, Jianchuan; Su, Yang; Iacob, Roxana E. Nature Communications, Vol. 10, Issue 1 https://doi.org/10.1038/s41467-019-13248-5	journal	December 2019
Pharmacokinetics and pharmacodynamics of Ro 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers Wittke, Bärbel; Mackie, Ian J.; Machin, Samuel J. British Journal of Clinical Pharmacology, Vol. 47, Issue 5 https://doi.org/10.1046/j.1365-2125.1999.00931.x	journal	May 1999
UR-3216: A New Generation Oral Platelet GPIIb / IIIa Antagonist Aga, Yasuhiro; Baba, Kosuke; Tam, Susan Current Pharmaceutical Design, Vol. 10, Issue 14 https://doi.org/10.2174/1381612043384592	journal	May 2004
Differential Antiplatelet Effects of Various Glycoprotein IIb–IIIa Antagonists Dickfeld, Timm; Ruf, Andreas; Pogatsa-Murray, Gisela Thrombosis Research, Vol. 101, Issue 2 https://doi.org/10.1016/S0049-3848(00)00385-6	journal	January 2001
A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafiban in patients Mould, D. Clinical Pharmacology & Therapeutics, Vol. 69, Issue 4 https://doi.org/10.1067/mcp.2001.114925	journal	April 2001
Complete integrin headpiece opening in eight steps Zhu, Jieqing; Zhu, Jianghai; Springer, Timothy A. The Journal of Cell Biology, Vol. 201, Issue 7 https://doi.org/10.1083/jcb.201212037	journal	June 2013
Platelet Activation and Atherothrombosis Davì, Giovanni; Patrono, Carlo New England Journal of Medicine, Vol. 357, Issue 24 https://doi.org/10.1056/NEJMra071014	journal	December 2007
XDS Kabsch, Wolfgang Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2 https://doi.org/10.1107/S0907444909047337	journal	January 2010
First Human Use of RUC‐4: A Nonactivating Second‐Generation Small‐Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point‐of‐Care Treatment of ST‐Segment–Elevation Myocardial Infarction Kereiakes, Dean J.; Henry, Tim D.; DeMaria, Anthony N. Journal of the American Heart Association, Vol. 9, Issue 17 https://doi.org/10.1161/JAHA.120.016552	journal	September 2020
Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. Frelinger, A. L.; Lam, S. C.; Plow, E. F. Journal of Biological Chemistry, Vol. 263, Issue 25 https://doi.org/10.1016/S0021-9258(18)37769-X	journal	September 1988
Integrins as therapeutic targets: lessons and opportunities Cox, Dermot; Brennan, Marian; Moran, Niamh Nature Reviews Drug Discovery, Vol. 9, Issue 10 https://doi.org/10.1038/nrd3266	journal	October 2010
How Natalizumab Binds and Antagonizes α ₄ Integrins Yu, Yamei; Schürpf, Thomas; Springer, Timothy A. Journal of Biological Chemistry, Vol. 288, Issue 45 https://doi.org/10.1074/jbc.M113.501668	journal	September 2013
Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial Ault, Kenneth A.; Cannon, Christopher P.; Mitchell, Jane Journal of the American College of Cardiology, Vol. 33, Issue 3 https://doi.org/10.1016/S0735-1097(98)00635-4	journal	March 1999
Activated Conformations of Very Late Activation Integrins Detected by a Group of Antibodies (HUTS) Specific for a Novel Regulatory Region(355-425) of the Common β1 Chain Luque, Alfonso; Gómez, Manuel; Puzon, Wilma Journal of Biological Chemistry, Vol. 271, Issue 19 https://doi.org/10.1074/jbc.271.19.11067	journal	May 1996
Conformational equilibria and intrinsic affinities define integrin activation Li, Jing; Su, Yang; Xia, Wei The EMBO Journal, Vol. 36, Issue 5 https://doi.org/10.15252/embj.201695803	journal	January 2017
Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa) Antagonists: Identification of 4-[4-[4-(Aminoimino methyl)phenyl]-1-piperazinyl]-1- piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent Eldred, Colin D.; Evans, Brian; Hindley, Sean Journal of Medicinal Chemistry, Vol. 37, Issue 23 https://doi.org/10.1021/jm00049a006	journal	November 1994
Intrinsic Activating Properties of GP IIb/IIIa Blockers Peter, Karlheinz; Schwarz, Meike; Nordt, Thomas Thrombosis Research, Vol. 103 https://doi.org/10.1016/S0049-3848(01)00300-0	journal	September 2001
Genome engineering using the CRISPR-Cas9 system Ran, F. Ann; Hsu, Patrick D.; Wright, Jason Nature Protocols, Vol. 8, Issue 11 https://doi.org/10.1038/nprot.2013.143	journal	October 2013
Orally Active Fibrinogen Receptor Antagonists. 2. Amidoximes as Prodrugs of Amidines Weller, Thomas; Alig, Leo; Beresini, Maureen Journal of Medicinal Chemistry, Vol. 39, Issue 16 https://doi.org/10.1021/jm9509298	journal	January 1996
RUC-4: A Novel αIIbβ3 Antagonist for Prehospital Therapy of Myocardial Infarction Li, Jihong; Vootukuri, Spandana; Shang, Yi Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 34, Issue 10 https://doi.org/10.1161/ATVBAHA.114.303724	journal	October 2014
Intact α _IIb β ₃ Integrin Is Extended after Activation as Measured by Solution X-ray Scattering and Electron Microscopy Eng, Edward T.; Smagghe, Benoit J.; Walz, Thomas Journal of Biological Chemistry, Vol. 286, Issue 40 https://doi.org/10.1074/jbc.M111.275107	journal	August 2011
Safety, Tolerability, Pharmacokinetics, and Time Course of Pharmacologic Response of the Active Metabolite of Roxifiban, XV459, a Glycoprotein IIb/IIIa Antagonist, following Oral Administration in Healthy Volunteers Pieniaszek, Henry J.; Sy, Sherwin K. B.; Ebling, William The Journal of Clinical Pharmacology, Vol. 42, Issue 7 https://doi.org/10.1177/009127002401102687	journal	July 2002
Energy landscape differences among integrins establish the framework for understanding activation Li, Jing; Springer, Timothy A. The Journal of Cell Biology, Vol. 217, Issue 1 https://doi.org/10.1083/jcb.201701169	journal	November 2017

Similar Records

INVESTIGATION OF THE STABILITY OF A PLASMA BY A GENERALIZED ENERGY PRINCIPLE

Journal Article · 1960 · Zhur. Eksptl'. i Teoret. Fiz. · OSTI ID:4142659

The Use of Inhibitors for Controlling Metal Corrosion. Part I. General Principles

Journal Article · 1948 · Metallurgia (England) Published August 1971 - December 1977 as Metall. Met. Form. · OSTI ID:4418244

Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1

Journal Article · 2020 · ACS Chemical Biology · OSTI ID:1635027

A general chemical principle for creating closure-stabilizing integrin inhibitors

Citation Formats

References (83)

Similar Records

Related Subjects